Jesup & Lamont downgrades PharmaNet Development (Nasdaq: PDGI) Neutral to Sell, citing lowered operating performance expectations.
This article: 81 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE